Antibody based therapeutic development for coronaviruses

Project: Research project

Project Details

Description

The first human coronavirus was isolated from individuals suffering from the common cold in the 1960’s. Since then, three highly pathogenic human coronaviruses have arisen in the last two decades; SARS in 2002, MERS in 2012 and the devastating COVID-19 pandemic. It is critical we understand how current and emerging coronaviruses infect humans and more importantly, develop therapeutic agents to tackle current disease, resist future SARS-CoV-2 variants and new coronavirus-origin pandemics.

StatusFinished
Effective start/end date9/15/208/31/23

Funding

  • National Science Foundation: $300,000.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.